Group One Trading, L.P. P Lx Pharma Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.3 $2,073 - $5,183	-17,277 Reduced 77.17%	5,110 $0
Q4 2022 Feb 09, 2023	SELL	$0.15 - $0.63 $1,980 - $8,318	-13,204 Reduced 37.1%	22,387 $3,000
Q3 2022 Nov 09, 2022	SELL	$0.52 - $3.08 $11,336 - $67,144	-21,800 Reduced 37.99%	35,591 $23,000
Q2 2022 Aug 11, 2022	SELL	$1.9 - $4.18 $25,270 - $55,593	-13,300 Reduced 18.81%	57,391 $139,000
Q1 2022 May 12, 2022	SELL	$3.54 - $8.3 $8,623 - $20,218	-2,436 Reduced 3.33%	70,691 $286,000
Q4 2021 Feb 11, 2022	BUY	$7.69 - $19.66 $68,848 - $176,015	8,953 Added 13.95%	73,127 $586,000
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $784,206 - $1.37 Million	64,174 New	64,174 $1.24 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.